Research Article

Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability

Volume: 8 Number: 3 September 30, 2025
EN

Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability

Abstract

Diabetic Retinopathy is one of the common complications of diabetes and can lead to permanent vision loss if left untreated. This study examined the performance of different AI-based methods for DR classification. Deep learning-based models, ResNet-50, DenseNet-121, U-Net, and classical CNN structures, along with traditional machine learning algorithms, SVM, Decision Trees, and k-Nearest Neighbor, were evaluated on the APTOS 2019 dataset. To optimize model performance, image data were subjected to various preprocessing steps, such as resizing, contrast correction, and denoising. Augmentation techniques were used to increase data diversity. According to experimental results, the most successful model was DenseNet-121, with an accuracy rate of 87% and an F1 score of 86%. In contrast, while classical machine learning methods produce lower accuracy values than deep learning, they exhibit consistent performance under certain conditions and offer a more computationally cost-effective alternative. The comparisons indicate the applicability of classical methods, especially in scenarios with limited data. This evaluation process creates a basic framework that will enable the integration of explainable artificial intelligence (XAI) approaches in later stages and is a preparation for adapting interpretation techniques such as SHAP and LIME to clinical decision support systems.

Keywords

References

  1. Yau, J. W., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., ... & Meta-Analysis for Eye Disease (META-EYE) Study Group. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes care, 35(3), 556-564.
  2. Seo, H., Park, S.-J., & Song, M. (2025). Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies. Cells, 14(5), 376.
  3. Gulshan, V., Peng, L., Coram, M., Stumpe, M. C., Wu, D., Narayanaswamy, A., ... & Webster, D. R. (2016). Development and validation of a deep learning algorithm for detecting diabetic retinopathy in retinal fundus photographs. jama, 316(22), 2402-2410.
  4. Ting, D. S. W., Cheung, C. Y. L., Lim, G., Tan, G. S. W., Quang, N. D., Gan, A., ... & Wong, T. Y. (2017). Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. Jama, 318(22), 2211-2223.
  5. Pratt, H., Coenen, F., Broadbent, D. M., Harding, S. P., & Zheng, Y. (2016). Convolutional neural networks for diabetic retinopathy. Procedia computer science, 90, 200-205.
  6. Sebastian, A., Elharrouss, O., Al-Maadeed, S., & Almaadeed, N. (2023). A survey on deep-learning-based diabetic retinopathy classification. Diagnostics, 13(3), 345.
  7. Rudin, C. (2019). Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nature machine intelligence, 1(5), 206-215.
  8. Ribeiro, M. T., Singh, S., & Guestrin, C. (2016, August). " Why should i trust you?" Explaining the predictions of any classifier. In Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining (pp. 1135-1144).

Details

Primary Language

English

Subjects

Computer Software , Software Testing, Verification and Validation

Journal Section

Research Article

Early Pub Date

September 29, 2025

Publication Date

September 30, 2025

Submission Date

July 31, 2025

Acceptance Date

August 29, 2025

Published in Issue

Year 2025 Volume: 8 Number: 3

APA
Telçeken, M., & Değirmenci, Ş. (2025). Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability. Sakarya University Journal of Computer and Information Sciences, 8(3), 510-517. https://doi.org/10.35377/saucis.8.94717.1754835
AMA
1.Telçeken M, Değirmenci Ş. Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability. SAUCIS. 2025;8(3):510-517. doi:10.35377/saucis.8.94717.1754835
Chicago
Telçeken, Muhammed, and Şeyma Değirmenci. 2025. “Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability”. Sakarya University Journal of Computer and Information Sciences 8 (3): 510-17. https://doi.org/10.35377/saucis.8.94717.1754835.
EndNote
Telçeken M, Değirmenci Ş (September 1, 2025) Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability. Sakarya University Journal of Computer and Information Sciences 8 3 510–517.
IEEE
[1]M. Telçeken and Ş. Değirmenci, “Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability”, SAUCIS, vol. 8, no. 3, pp. 510–517, Sept. 2025, doi: 10.35377/saucis.8.94717.1754835.
ISNAD
Telçeken, Muhammed - Değirmenci, Şeyma. “Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability”. Sakarya University Journal of Computer and Information Sciences 8/3 (September 1, 2025): 510-517. https://doi.org/10.35377/saucis.8.94717.1754835.
JAMA
1.Telçeken M, Değirmenci Ş. Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability. SAUCIS. 2025;8:510–517.
MLA
Telçeken, Muhammed, and Şeyma Değirmenci. “Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability”. Sakarya University Journal of Computer and Information Sciences, vol. 8, no. 3, Sept. 2025, pp. 510-7, doi:10.35377/saucis.8.94717.1754835.
Vancouver
1.Muhammed Telçeken, Şeyma Değirmenci. Artificial Intelligence-Based Screening for Diabetic Retinopathy: Model Comparison and Interpretability. SAUCIS. 2025 Sep. 1;8(3):510-7. doi:10.35377/saucis.8.94717.1754835

 

INDEXING & ABSTRACTING & ARCHIVING

 

31045 31044   ResimLink - Resim Yükle  31047 

31043 28939 28938 34240
 

 

29070    The papers in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License